Symptoma

Gangliosidosis

GM1-Gangliosidosis

Only the infantile form has the typical cherry red spot in the macula but is present in only about 50% of infants. [disorders.eyes.arizona.edu]

CBC count Vacuolation of lymphocytes may be present in patients with G M1 gangliosidosis but is a nonspecific. [omicsonline.org]

Case presentation Present case is a one year old male born to 3rd degree consanguineous Indian parents from Maharashtra. He was presented with global developmental delay, hypotonia and sensitive to hyperacusis. [bmcpediatr.biomedcentral.com]

The severity of symptoms and the time at which they first present can vary greatly in GM1 gangliosidosis. [childrenshospital.org]

Kannebley et al18 also reported that no patient presented Parkinsonism. We organized our findings based on patient age (as seen in Tables 2 and 3). In so doing, we expecting to identify early presenting and late‐presenting abnormalities. [onlinelibrary.wiley.com]

  • Pallor

    Affected infants will have corneal clouding and the presence of macular pallor (the cherry-red spot) in the eye typical of that seen in Tay-Sachs disease, another lysosomal storage disease. [themedicalbiochemistrypage.org]

  • Death in Childhood

    The juvenile form, type II, has a later onset with psychomotor deterioration, seizures and skeletal changes apparent between 7 and 36 months and death in childhood. Visceral involvement and cherry-red spots are usually not present. [disorders.eyes.arizona.edu]

  • Brachydactyly

    Hepatomegaly, coarse facial features, brachydactyly, and cardiomyopathy with valvular dysfunction are common. Dermal melanocytosis has also been described in infants in a pattern some have called Mongolian spots. [disorders.eyes.arizona.edu]

    Skeletal abnormalities: Lumbar gibbus deformity and kyphoscoliosis, Dysostosis multiplex, Broad hands and feet, Brachydactyly, Joint contractures, Prominent dermal melanocytosis [ 14 - 17 ]. [omicsonline.org]

  • Retinal Hemorrhage

    Decreased acuity, nystagmus, strabismus and retinal hemorrhages have been described. Systemic Features: Infants with type I disease are usually hypotonic from birth but develop spasticity, psychomotor retardation, and hyperreflexia within 6 months. [disorders.eyes.arizona.edu]

  • Depressed Nasal Bridge

    Infants have coarse thick hair, a depressed nasal bridge, gingival hypertrophy, large low-set ears and hair on the forehead. [themedicalbiochemistrypage.org]

    Opthalmaologic features: Macular cherry-red spots, Optic atrophy, Corneal clouding Dysmorphic features: Frontal bossing, Depressed nasal bridge and broad nasal tip, Large low-set ears, Long philtrum, Gingival hypertrophy and macroglossia [1], Coarse skin [omicsonline.org]

Workup for her over several years included routine blood tests, alpha-fetoprotein, vitamin E, copper, and ceruloplasmin titers, which were negative. [movementdisorders.org]

Ensuing blood tests came back inconclusive and Armand’s parents, Tim Hayes and Lindy Sutton, were referred to Cincinnati Children’s Hospital Medical Center where a full workup was ordered including an MRI, muscle biopsy, chest x-rays and a DNA workup. [daytondailynews.com]

The first clinical trial of a gene therapy treatment based on discoveries made by UMass Medical School and Auburn University researchers has been administered in a child at the National Institutes of Health. The treatment took place in May. [umassmed.edu]

Treatment Treatment Options: There is no treatment that effectively alters the disease course. References [disorders.eyes.arizona.edu]

This review outlines current knowledge pertaining the pathobiology as well as potential innovative treatments for the GM2 gangliosidoses. [eurekaselect.com]

Last updated: 11/17/2015 There is currently no effective medical treatment for GM1 gangliosidosis.[3][4] Symptomatic treatment for some of the neurologic signs and symptoms is available, but does not significantly alter the progression of the condition [rarediseases.info.nih.gov]

Management and treatment Treatment for patients with GM1 gangliosidosis is symptomatic and supportive. Prognosis Prognosis is very poor with life-expectancy rarely exceeding 2 years. [orpha.net]

Prognosis Prognosis is very poor with life-expectancy rarely exceeding 2 years. Causes of death include pneumonia due to recurrent aspiration and cardiopulmonary failure. [orpha.net]

[…] but has not yet advanced to human trials.[4][7] Neurologic and orthopedic sequelae may prevent adequate physical activity, but affected individuals may benefit from physical and occupational therapy.[4] Last updated: 8/6/2012 The long-term outlook (prognosis [rarediseases.info.nih.gov]

Prognosis Children with early infantile GM1 often die by age 3 from cardiac complications or pneumonia. Children with the early-onset form of Tay-Sachs disease often die by age 4 from recurring infection. [brainfacts.org]

Prognosis Infantile (type 1): Death usually occurs during the second year of life because of infection and cardiopulmonary failure. [1] Juvenile (type 2): Death usually occurs before the second decade of life. [1] Adult (type 3): Phenotypic variability [emedicine.medscape.com]

[…] bilateral globus pallidi in a “wish bone” distribution, suggestive of mineralization Click here to view In our patient, childhood-onset progressive dystonia with prominent orofacial and laryngeal involvement and auditory startle suggested a secondary etiology [neurologyindia.com]

Etiology GM1 gangliosidosis is caused by mutations in the GLB1 gene (3p22.3) coding for beta-galactosidase. Diagnostic methods Diagnosis is based on clinical signs although classic signs are not always present at diagnosis. [orpha.net]

Summary Epidemiology Type 1 is the most frequent form of GM1 gangliosidosis but the exact prevalence is not known. About 200 cases have been reported to date. [orpha.net]

Symptoms: Symptoms can appear within a few months after birth and include the inability to swallow or trouble feeding, loss of head control, missed developmental milestones, seizures, blindness and osteoporosis Epidemiology: The incidence of GM1 gangliosidosis [axovant.com]

[…] mitochondrial mass, morphology, and function. [12] Altered mitochondrial morphology could lead to a reduced availability of ATP at synapses, leading to some of the impaired neurotransmission and neuronal degradation seen in lysosomal storage disorders. [13, 12] Epidemiology [emedicine.medscape.com]

Journal Cell Mol Life Sci 65:351-3 (2008) DOI:10.1007/s00018-008-7470-2 Reference PMID:12019216 (GM2) Authors Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL Title Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by [genome.jp]

[…] history of ET and positive response to propranolol, [9] as well as cases of PWT and writers cramp in the same patient described in the literature. [7] The clinical features noted in our patient at least make a strong argument for dystonia being the pathophysiological [movementdisorders.org]

Adult (type 3): The adult subtype is marked by normal early neurologic development with no physical stigmata and subsequent development of a slowly progressive dementia with parkinsonian features, extrapyramidal disease, and dystonia. [3, 4, 5] Pathophysiology [emedicine.medscape.com]

[…] treatment due to its success in other lysosomal storage disorders.[4] Active research in the areas of enzyme replacement and gene therapy for the condition is ongoing but has not yet advanced to human trials.[4][7] Neurologic and orthopedic sequelae may prevent [rarediseases.info.nih.gov]

The FDA’s Office of Orphan Products Development (OOPD) grants orphan designation status to drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases or conditions that affect fewer than 200,000 [biospace.com]

In this study, the ketogenic diet will be used to minimize or prevent gastrointestinal side-effects of miglustat. [clinicaltrials.gov]

Based on this, family was provided genetic counseling about the future recurrence risks of the disease and prevention by prenatal diagnosis. [bmcpediatr.biomedcentral.com]

This leads to alteration in the pocket shape, which would prevent keratan sulfate from entering the active site. This causes a loss of catalytic activity especially toward glycosaminoglycans containing keratan sulfate. [nature.com]